URL copied
Bharat Biotech's Karnataka facility to manufacture 5 crore Covaxin doses by August-end
Bharat Biotech's Covaxin manufacturing facility that is under construction in Kolar district in Karnataka would have a manufacturing capacity of four to five crore doses a month by August-end, state Health Minister Dr K Sudhakar said on Monday.
Talking to reporters here ahead of his meeting with the experts on mucormycosis, known as as black fungus, which is emerging as a new threat to those who recover from COVID- 19, Sudhakar said he had a video conference with Bharat Biotech founder Dr Krishna Ella, his daughter Dr Jala Ella and rest of the team.